Waltham, Massachusetts-based Thermo Fisher Scientific Inc. (TMO) provides life sciences solutions, analytical instruments, ...

The stock's fall snapped a four-day winning streak.

Thermo Fisher Scientific is breaking out the big bills to score a clinical research treat. With $8.875 billion in cash, the ...

Thermo Fisher Scientific has cleared a major regulatory hurdle in getting a new diagnostic tool for a type of blood cancer in ...

Thermo Fisher Scientific received 510 (k) clearance from the Food and Drug Administration to market its EXENT system to aid in the diagnosis of multiple myeloma. The company's EXENT system detects and ...

Private equity-backed Clario brings to Thermo Fisher Scientific software that collects, manages, and analyzes clinical trial ...

NVIDIA, Micron Technology and Thermo Fisher lead today's top analyst picks, each showing strong growth trends and strategic advances.

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced 510(k) clearance of the EXENT® Analyser and Immunoglobulin Isotypes (GAM) Assay**, a first-of-its-kind ...

Thermo Fisher’s Jennifer Cannon reviews the first year of the company’s Accelerator Drug Development suite of services and ...

Thermo Fisher Scientific shares rise after announcing $8.875B acquisition of Clario, enhancing AI-powered clinical trials and digital drug development capabilities.

Thermo Fisher Scientific has agreed to acquire Clario Holdings for up to $9.4 billion in cash and future-earnout payments.

The new system addresses challenges around food and water quality testing in the face of contaminants such as per- and ...